Lupin falls 3% as USFDA issues 5 observations for Vizag facility

The United States Food and Drug Administration (USFDA) carried out the inspection of the company's Vizag API manufacturing facility between January 13, 2020 and January 17, 2020.

from Home Page https://ift.tt/30znVLJ